Latest Regulatory Risks News

VHM Limited has secured approval for its Cultural Heritage Management Plan at the Goschen Project, clearing a vital regulatory hurdle and enabling formal lodgement of its Work Plan to progress development.

Jumbo Interactive has acquired Dream Giveaway, a leading US digital prize draw business, marking its strategic entry into the lucrative American B2C prize market. The A$55.4 million deal leverages Dream Giveaway’s established brand and loyal customer base to accelerate Jumbo’s international growth.

Pivotal Metals Limited has announced a C$2.6 million flow-through share offer targeting Canadian investors, aimed at funding critical minerals exploration in Quebec. The offer complements a concurrent institutional placement, underscoring the company’s aggressive growth strategy amid significant operational risks.

Gold Hydrogen Limited has closed a $14.5 million strategic investment round led by Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, positioning the company to accelerate drilling and commercialisation efforts at its Ramsay Project in South Australia.

Golden Dragon Mining Ltd is set to raise $5 million through an IPO, aiming for ASX listing with a portfolio of promising gold and nickel exploration projects in Western Australia.

Newmont Corporation reported a strong third quarter in 2025, driven by higher gold prices and successful divestitures of non-core assets, enhancing liquidity and reducing debt. The company’s operational shifts and cost management reflect a strategic pivot in a volatile market.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.

Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.

Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.